All results

1 results for breast cancer

• PVT-2201-301

  This is a phase 3, multicenter, randomized, placebo-controlled, double-blind study of treatment with brepocitinib (TYK2/JAK1 inhibitor) in adults with…

  Ages

  18 Years - 75 Years

  Sexes

  All